Literature DB >> 19923097

[Analysis of predictive tools for further axillary involvement in patients with sentinel-lymph-node-positive, small (< or =15 mm) invasive breast cancer].

Gábor Cserni1, Rita Bori, István Sejben, Gábor Boross, Róbert Maráz, Mihály Svébis, Mária Rajtár, Eliza Tekle Wolde, Eva Ambrózay.   

Abstract

Small breast cancers often require different treatment than larger ones. The frequency and predictability of further nodal involvement was evaluated in patients with positive sentinel lymph nodes and breast cancers < or =15 mm by means of 8 different predictive tools. Of 506 patients with such small tumors 138 with positive sentinel nodes underwent axillary dissection and 39 of these had non-sentinel node involvement too. The Stanford nomogram and the micrometastatic nomogram were the predictive tools identifying a small group of patients with low probability of further axillary involvement that might not require completion axillary lymph node dissection. Our data also suggest that the Tenon score can separate subsets of patients with a low and a higher risk of non-sentinel node metastasis. Predictive tools based on multivariate models can help in omitting completion axillary dissection in patients with low risk of non-sentinel lymph node metastasis based on their small tumor size.

Entities:  

Mesh:

Year:  2009        PMID: 19923097     DOI: 10.1556/OH.2009.28699

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Patients' choice on axillary lymph node dissection following sentinel lymph node micrometastasis--first report on prospective use of a nomogram in very low risk patients.

Authors:  Gábor Cserni; Istvánné Bezsenyi; László Markó
Journal:  Pathol Oncol Res       Date:  2012-10-16       Impact factor: 3.201

2.  Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis.

Authors:  Gábor Cserni; Rita Bori; Róbert Maráz; Marjut H K Leidenius; Tuomo J Meretoja; Paivi S Heikkila; Peter Regitnig; Gero Luschin-Ebengreuth; Janez Zgajnar; Andraz Perhavec; Barbara Gazic; György Lázár; Tibor Takács; András Vörös; Riccardo A Audisio
Journal:  Pathol Oncol Res       Date:  2012-07-14       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.